Gan & Lee Insulin Glargine Target Type (2) Evaluating Research

Clinical trial NCT03371108 · COMPLETED

Trial details

NCT number: NCT03371108
Sponsor: Gan and Lee Pharmaceuticals, USA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2017-10-31
Primary completion: 2019-04-17
Enrollment: 567

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.